Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
No Result
View All Results

Studies » Andalusia invests in research into Leishmaniasis, West Nile Virus and Multiple Sclerosis

Andalusia invests in research into Leishmaniasis, West Nile Virus and Multiple Sclerosis

The Andalusian Ministry of Health and Consumer Affairs will subsidise three non-competitive research projects based on Leishmaniasis, West Nile Virus and Multiple Sclerosis, with a budget of 250,000 euros.

by Basem Rousan
January 8, 2025
Reading time: 2 mins read
A laboratory with a person using a micropipette to take liquid from a flask, surrounded by test tubes and other scientific tools.

Andalusian Government

Share on BlueskyShare on TwitterShare on Linkedin
  • Author
  • Recent Posts
Basem Rousan
Basem Rousan
Economist at Vitals Today
Our economics expert brings a unique perspective from the world of banking and finance. With a strong track record in investment and economic trends analysis, Basem focuses on business developments in the healthcare sector.
Basem Rousan
Latest posts by Basem Rousan (see all)
  • GE HealthCare invests $138 million in manufacturing facility to meet growing demand for contrast media - January 31, 2025
  • PureHealth Abu Dhabi acquires Hellenic Healthcare’s 60% and strengthens its global expansion - January 27, 2025
  • Ecuador promotes strategic alliances to improve care for chronic diseases - January 25, 2025

The Ministry of Health and Consumption of Andalusia will finance three research projects related to Leishmaniasis, West Nile Virus and Multiple Sclerosis. A total budget of 250,000 euros will be allocated for this purpose.

This investment The call for proposals is carried out through the General Secretariat for Public Health and R&D&I in Health. The non-competitive call, published on October 14, 2024, allowed for the selection of projects in the areas of zoonoses and emerging risks, as well as in multiple sclerosis. After evaluating the applications, the funds were allocated for three projects that will be developed over the next two years.

Research on Multiple Sclerosis

The first project has 125,000 euros in funding and is managed by the Foundation for Health Research Management of Seville (FISEVIA). This study is being carried out at the Institute of Biomedicine of Seville (IBiS) and seeks to identify the molecular targets of the protective action of melatonin in the immunopathology of multiple sclerosis.

Principal investigators Antonio Carrillo Vico and Ana Isabel Álvarez López will analyze the cellular and molecular effects of melatonin to better understand the immunomodulatory and neuroprotective mechanisms of this molecule, which is widely linked to immunity but whose molecular targets are still unclear. This breakthrough could allow the development of new therapies.

'LeishAndalus' project

The second project, called 'LeishAndalus', will receive funding of 65,000 euros. It is led by the Foundation for Biomedical Research of Córdoba (FIBICO) and will analyse the circulation of Leishmania spp. in humans and domestic and wild animal reservoirs in Andalusia. This analysis seeks to improve surveillance and prevention strategies for human leishmaniasis. The principal investigators are Antonio Rivero Juárez and Moisés Gonzálvez Juan.

Westinlealert project

The third project, called 'Westinlealert', has a budget of 60,000 euros and will also be carried out by FIBICO. This study is being carried out by the Competitive Research Unit on Zoonoses and Emerging Diseases (ENZOEM). The objective is to evaluate the role of birds in the ecoepidemiology of the West Nile Virus in Andalusia. In addition, it seeks to develop an early warning tool to predict outbreaks. The project leaders are María de los Ángeles Risalde Moya and Ignacio García Bocanegra, researchers with extensive experience in the study of this virus.

These projects reflect Andalusia's commitment to public health research, addressing diseases relevant to the region and developing innovative prevention and treatment tools.

Tags: FeaturedSpainInnovation
Previous Post

Kounis syndrome: the acute coronary syndrome that fuses cardiology and allergies

Next Post

Hedia and Glooko partner to improve diabetes control with personalized bolus insulin

Related Stories

A dark-haired doctor, wearing a white coat and a stethoscope around his neck, is having an animated conversation with a patient in a modern doctor's office setting, with a computer and illuminated windows in the background.
Health

What is Mupirocin and what skin infections is it used for?

September 25, 2025
White package on a table inside a doctor's office, with an examination chair and medical equipment visible in the background.
Health

Monurol for cystitis: How long does it take to relieve the itching?

September 16, 2025
Ozempic
Health

Why is Ozempic cheaper in Spain than in the US?

September 25, 2025
One hand holds an injection device, showing a needle and dose indicator, while the other hand holds an orange container of medication.
Health

Can Ozempic be purchased without a prescription at pharmacies in Spain?

September 25, 2025
Load More

Most Shared

  • A person holds a blue injection device in their hands, with an additional cartridge and several disposable needles on a wooden table.

    Ozempic in Spain: How much does it cost and how to get it?

    2 shared
    Share 1 Tweet 1
  • Mounjaro in Spain: When did it arrive and what's its price?

    4 shared
    Share 2 Tweet 1
  • Can I mix Enantyum and Paracetamol if the pain is very severe?

    2 shared
    Share 1 Tweet 1
  • Dexketoprofen vs. Ibuprofen: Which is better for pain?

    1 shared
    Share 0 Tweet 0
  • Can Ozempic be purchased without a prescription at pharmacies in Spain?

    0 shares
    Share 0 Tweet 0

logo for Vitals Today, your trusted source for health news, a green heart with the words Vitals Today, all in green

Vitals Today, your trusted source for healthcare news. Stay updated on the latest studies, regulations, and industry initiatives.

  • LinkedIn
  • X
  • Bluesky
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
  • Contact

© 2024 Vitals Today - all rights reserved

Manage consent

To deliver the best experiences, we use technologies such as cookies to store and/or access device information. Accepting these technologies will allow us to process data such as browsing behavior or unique identifiers on this site. Not accepting or withdrawing consent may negatively impact certain features and functionality.

Functional Always active
Technical storage or access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Technical storage or access is necessary to create user profiles for the purpose of sending advertising, or to track the user on a website or across multiple websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Results
  • Portal
  • Breaking News
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español

© 2024 Vitals Today - all rights reserved